BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 15593084)

  • 21. A matched case-control study on the prognosis of native kidney neoplasia in renal transplant recipients.
    Grochowiecki T; Szmidt J; Nazarewski S; Galazka Z; Durlik M; Borkowski T; Borkowski A; Wojtaszek M
    Transpl Int; 2002 Oct; 15(9-10):455-8. PubMed ID: 12389076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal adenoma and oncocytoma.
    Licht MR
    Semin Urol Oncol; 1995 Nov; 13(4):262-6. PubMed ID: 8595549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
    Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
    Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma of native kidneys in renal transplant patients.
    Klatte T; Marberger M
    Curr Opin Urol; 2011 Sep; 21(5):376-9. PubMed ID: 21730855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopsy-confirmed de novo renal cell carcinoma (RCC) in renal grafts: a single-centre management experience in a 2396 recipient cohort.
    Ploussard G; Chambade D; Meria P; Gaudez F; Tariel E; Verine J; De Bazelaire C; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    BJU Int; 2012 Jan; 109(2):195-9. PubMed ID: 21810160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urological de novo malignancy after kidney transplantation: a case for the urologist.
    Melchior S; Franzaring L; Shardan A; Schwenke C; Plümpe A; Schnell R; Dreikorn K
    J Urol; 2011 Feb; 185(2):428-32. PubMed ID: 21167532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening computed tomography: will it result in overdiagnosis of renal carcinoma?
    Fenton JJ; Weiss NS
    Cancer; 2004 Mar; 100(5):986-90. PubMed ID: 14983494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The high rate of de novo graft carcinomas in renal transplant recipients.
    Viart L; Surga N; Collon S; Jaureguy M; Elalouf V; Tillou X
    Am J Nephrol; 2013; 37(2):91-6. PubMed ID: 23363786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.
    Serrano MF; Katz M; Yan Y; Kibel AS; Humphrey PA
    Cancer; 2008 Aug; 113(3):477-83. PubMed ID: 18484589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease.
    Schwarz A; Vatandaslar S; Merkel S; Haller H
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):750-6. PubMed ID: 17699492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living-donor renal transplantation of grafts with incidental renal masses after ex-vivo partial nephrectomy.
    Sener A; Uberoi V; Bartlett ST; Kramer AC; Phelan MW
    BJU Int; 2009 Dec; 104(11):1655-60. PubMed ID: 19594738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal transplantation in patients with Balkan endemic nephropathy.
    Basic-Jukic N; Hrsak-Puljic I; Kes P; Bubic-Filipi L; Pasini J; Hudolin T; Kastelan Z; Reiner Z; Kordic M; Brunetta B; Juric I
    Transplant Proc; 2007 Jun; 39(5):1432-5. PubMed ID: 17580155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of bilateral renal cell cancer.
    Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
    J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
    Diller R; Gruber A; Wolters H; Senninger N; Spiegel HU
    Transplant Proc; 2005 Jun; 37(5):2089-92. PubMed ID: 15964347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.